William P. Mr. Burke - 23 Aug 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Reporting relationship: EVP, Chief Financial Officer
Issuer ticker: HAE
Reported as of: 23 Aug 2021
Net transaction value: -$511,180
SEC form: 4
Accepted by SEC: 25 Aug 2021, 16:15:51 UTC
Prior SEC filing: 06 Jul 2021
Next SEC filing: 05 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Michelle Basil, attorney-in-fact for Mr. Burke

Key filing fact

William P. Mr. Burke filed Form 4 for HAEMONETICS CORP (HAE) on 25 Aug 2021.

Key facts

This page summarizes William P. Mr. Burke's Form 4 filing for HAEMONETICS CORP (HAE).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 25 Aug 2021, 16:15.

Change

Previous filing in this sequence was filed on 06 Jul 2021.
Current net transaction value: -$511,180.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HAE transaction

Common Stock

Options Exercise

Transaction value: $384,247
Shares: +11,232
Change %: +37%
Price: $34.21
Shares after: 41,523
Date: 23 Aug 2021
Ownership: Direct
Footnotes: F3

HAE transaction

Common Stock

Options Exercise

Transaction value: $476,153
Shares: +11,435
Change %: +28%
Price: $41.64
Shares after: 52,958
Date: 23 Aug 2021
Ownership: Direct
Footnotes: F3

HAE transaction

Common Stock

Sale

Transaction value: $1,371,580
Shares: -22,667
Change %: -43%
Price: $60.51
Shares after: 30,291
Date: 23 Aug 2021
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HAE transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -11,232
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 23 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,232
Exercise price: $34.21
Footnotes: F1

HAE transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -11,435
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 23 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,435
Exercise price: $41.64
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Transaction pursuant to an existing 10b5-1 trading plan.

Footnote F2

Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

This number includes unvested RSUs previously reported.